SomaLogic, Inc. SLGC
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| (1) BlackRock, Inc. | Delaware | 9970344 | 0 | 10268281 | 0 | 10268281 | 5.5 % | 03/02/2023 |
| Lawrence Marshall Gold | United States | 0 | 9133066 | 0 | 9133066 | 9133066 | 5.04 % | 11/02/2022 |
| Novartis Pharma AG | Switzerland | 0 | 8691140 | 0 | 8691140 | 8691140 | 4.8 % | 08/10/2021 |
| Novartis Institutes for BioMedical Research, Inc. | Delaware | 0 | 1676200 | 0 | 1676200 | 1676200 | 0.9 % | 08/10/2021 |
| Novartis AG | Switzerland | 0 | 10367340 | 0 | 10367340 | 10367340 | 5.7 % | 08/10/2021 |
| KEITH A. MEISTER | United States of America | 2500000 | 11146669 | 2500000 | 10 | 13646669 | 7.4 % | 15/09/2021 |
| CMLS HOLDINGS II LLC | Delaware | 0 | 11146669 | 0 | 10 | 11146669 | 6 % | 15/09/2021 |
| KEITH A. MEISTER | 2500000 | 11146669 | 2500000 | 11146669 | 13646669 | 7.4 % | 15/09/2021 | |
| C-LSH II LLC | Delaware | 0 | 11146669 | 0 | 10 | 11146669 | 6 % | 15/09/2021 |
| CASDIN CAPITAL, LLC | United States of America | 0 | 12389082 | 0 | 10 | 12389082 | 6.8 % | 15/09/2021 |
| CASDIN PARTNERS GP, LLC | United States of America | 0 | 9916812 | 0 | 10 | 9916812 | 5.5 % | 15/09/2021 |
| CASDIN PARTNERS MASTER FUND, L.P. | United States of America | 0 | 9916812 | 0 | 10 | 9916812 | 5.5 % | 15/09/2021 |
| ELI CASDIN | United States of America | 0 | 23535751 | 0 | 10 | 23535751 | 12.7 % | 15/09/2021 |
| ARK Investment Management LLC | Delaware, United States | 2847175 | 0 | 2847175 | 0 | 2847175 | 10.32 % | 09/07/2021 |
| Gagnon | USA | 134851 | 1257405 | 134851 | 0 | 1454690 | 5.3 % | 08/04/2021 |
| GAGNON ADVISORS, LLC | Limited Liability Company | 0 | 366905 | 0 | 0 | 366905 | 0.1 % | 08/04/2021 |
| Securities LLC | Limited Liability Company | 0 | 819920 | 0 | 0 | 876911 | 3 % | 08/04/2021 |